Vandetanib (ZD6474), a dual inhibitor of vascular endothelial growth factor receptor (VEGFR) and epidermal growth factor receptor (EGFR) tyrosine kinases: current status and future directions. (Q37435425)
Jump to navigation
Jump to search
scientific article published on 06 April 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Vandetanib (ZD6474), a dual inhibitor of vascular endothelial growth factor receptor (VEGFR) and epidermal growth factor receptor (EGFR) tyrosine kinases: current status and future directions. |
scientific article published on 06 April 2009 |
Statements
Vandetanib (ZD6474), a dual inhibitor of vascular endothelial growth factor receptor (VEGFR) and epidermal growth factor receptor (EGFR) tyrosine kinases: current status and future directions (English)
Fabiano Falasconi
Gianfranco De Feo
Antonia Del Giudice
Jane Bryce
Ermelinda De Maio
Francesco Perrone
Maria Carmela Piccirillo